PDB Short entry for 1RNE HEADER HYDROLASE(ACID PROTEINASE) 12-DEC-91 1RNE TITLE THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE TITLE 2 AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.15; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: OVARY KEYWDS HYDROLASE(ACID PROTEINASE) EXPDTA X-RAY DIFFRACTION AUTHOR M.G.GRUETTER,J.RAHUEL,J.P.PRIESTLE REVDAT 6 21-OCT-20 1RNE 1 CAVEAT COMPND REMARK HET REVDAT 6 2 1 HETNAM HETSYN LINK ATOM REVDAT 5 29-JUL-20 1RNE 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE REVDAT 4 29-NOV-17 1RNE 1 HELIX REVDAT 3 24-FEB-09 1RNE 1 VERSN REVDAT 2 01-APR-03 1RNE 1 JRNL REVDAT 1 31-OCT-93 1RNE 0 JRNL AUTH J.RAHUEL,J.P.PRIESTLE,M.G.GRUTTER JRNL TITL THE CRYSTAL STRUCTURES OF RECOMBINANT GLYCOSYLATED HUMAN JRNL TITL 2 RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG JRNL TITL 3 INHIBITOR. JRNL REF J.STRUCT.BIOL. V. 107 227 1991 JRNL REFN ISSN 1047-8477 JRNL PMID 1807356 JRNL DOI 10.1016/1047-8477(91)90048-2 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.R.SIELECKI,K.HAYAKAWA,M.FUJINAGA,M.E.P.MURPHY,M.FRASER, REMARK 1 AUTH 2 A.K.MUIR,C.T.CARILLI,J.A.LEWICKI,J.D.BAXTER,M.N.G.JAMES REMARK 1 TITL STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR REMARK 1 TITL 2 CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION REMARK 1 REF SCIENCE V. 243 1346 1989 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.SALI,B.VEERAPANDIAN,J.B.COOPER,S.I.FOUNDLING,D.J.HOOVER, REMARK 1 AUTH 2 T.L.BLUNDELL REMARK 1 TITL HIGH-RESOLUTION X-RAY DIFFRACTION STUDY OF THE COMPLEX REMARK 1 TITL 2 BETWEEN ENDOTHIAPEPSIN AND AN OLIGOPEPTIDE INHIBITOR: THE REMARK 1 TITL 3 ANALYSIS OF THE INHIBITOR BINDING AND DESCRIPTION OF THE REMARK 1 TITL 4 RIGID BODY SHIFT IN THE ENZYME REMARK 1 REF EMBO J. V. 8 2179 1989 REMARK 1 REFN ISSN 0261-4189 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 138 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RNE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176135. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.70000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.45000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.35000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.45000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 82.05000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.45000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 27.35000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.45000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.45000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 82.05000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 54.70000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 109.40000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 355 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A -5 REMARK 465 THR A -4 REMARK 465 LEU A -3 REMARK 465 GLY A -2 REMARK 465 SER A 158A REMARK 465 GLU A 158B REMARK 465 ASN A 158C REMARK 465 SER A 158D REMARK 465 GLN A 158E REMARK 465 SER A 158F REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 44 CD CE NZ REMARK 470 ARG A 47 CD NE CZ NH1 NH2 REMARK 470 GLU A 70 CD OE1 OE2 REMARK 470 ARG A 132 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 147 CE NZ REMARK 470 ASP A 158 CA C O CB CG OD1 OD2 REMARK 470 SER A 226 OG REMARK 470 LYS A 238 CD CE NZ REMARK 470 LYS A 265 CE NZ REMARK 470 LYS A 281B CG CD CE NZ REMARK 470 ARG A 316 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 67 O5 NAG A 345 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 106 CD GLU A 106 OE1 0.079 REMARK 500 GLU A 116 CD GLU A 116 OE2 0.068 REMARK 500 GLU A 207 CD GLU A 207 OE1 0.070 REMARK 500 GLU A 278 CD GLU A 278 OE1 0.084 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 32 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP A 57 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 60 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 SER A 85 N - CA - CB ANGL. DEV. = 9.6 DEGREES REMARK 500 PHE A 112 CB - CG - CD2 ANGL. DEV. = 4.8 DEGREES REMARK 500 ASP A 118 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP A 118 CB - CG - OD2 ANGL. DEV. = -8.9 DEGREES REMARK 500 ASP A 138 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 138 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 149 CB - CG - OD1 ANGL. DEV. = -7.4 DEGREES REMARK 500 ASP A 149 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG A 157 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ASP A 208 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 208 CB - CG - OD2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ASP A 257 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 257 CB - CG - OD2 ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP A 273 CB - CG - OD1 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 273 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TYR A 274 CB - CG - CD2 ANGL. DEV. = -6.9 DEGREES REMARK 500 TYR A 274 CB - CG - CD1 ANGL. DEV. = 4.5 DEGREES REMARK 500 MET A 289 CG - SD - CE ANGL. DEV. = -16.9 DEGREES REMARK 500 ASP A 290 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ARG A 307 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 TYR A 310 CB - CG - CD1 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG A 319 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 67 -67.49 -129.17 REMARK 500 ARG A 132 18.24 49.50 REMARK 500 VAL A 145 -18.79 -142.11 REMARK 500 GLN A 277 77.08 -67.36 REMARK 500 LYS A 281C 108.50 -163.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE ATOMS OF NAG 345 WERE ASSIGNED OCCUPANCIES OF 0.5 TO REMARK 600 KEEP B-FACTORS FROM GOING OVER 100 ANGSTROMS SQUARED. REMARK 600 REMARK 600 THE INHIBITOR CGP 38'560 IS A TRANSITION-STATE ANALOGUE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC ASPARTIC ACID RESIDUES REMARK 800 REMARK 800 SITE_IDENTIFIER: S4 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: S3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: S2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: S1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: S1' REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 1' REMARK 800 REMARK 800 SITE_IDENTIFIER: S2' REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: SUBSTRATE BINDING SUBSITE 2' DBREF 1RNE A -5 326 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG MODRES 1RNE ASN A 67 ASN GLYCOSYLATION SITE HET NAG A 345 14 HET C60 A 350 51 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM C60 [[[3-(2-METHYL-PROPANE-2-SULFONYL)-1-BENZENYL]-2- HETNAM 2 C60 PROPYL]-CARBONYL-HISTIDYL]-AMINO-[CYCLOHEXYLMETHYL]- HETNAM 3 C60 [2-HYDROXY-4-ISOPROPYL]-PENTAN-5-OIC ACID BUTYLAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 C60 C39 H63 N5 O6 S FORMUL 4 HOH *138(H2 O) HELIX 1 H1 TYR A 47B TYR A 52 1MIXED 3/10 AND ALPHA HELIX 6 HELIX 2 H2 PRO A 108 ALA A 115 1MIXED 3/10 AND ALPHA HELIX 8 HELIX 3 H3 PRO A 135 GLY A 144 1 10 HELIX 4 H4 SER A 224 GLY A 236 1 13 HELIX 5 H5 LYS A 248 THR A 254 5IRREGULAR 7 HELIX 6 H6 GLY A 302 PHE A 309 1 8 SHEET 1 S1 6 ASN A 178 VAL A 189 0 SHEET 2 S1 6 ARG A 319 ALA A 325 -1 N ILE A 320 O ILE A 182 SHEET 3 S1 6 PHE A 309 ARG A 315 -1 N GLU A 312 O GLY A 321 SHEET 4 S1 6 GLU A 148 ARG A 157 -1 N PHE A 151 O PHE A 313 SHEET 5 S1 6 GLY A 162 GLY A 168 -1 N GLN A 164 O TYR A 154 SHEET 6 S1 6 THR A 0 TYR A 9 -1 N VAL A 4 O ILE A 165 SHEET 1 S2 7 GLN A 13 GLY A 21 0 SHEET 2 S2 7 PRO A 24 THR A 33 -1 N PHE A 27 O ILE A 18 SHEET 3 S2 7 ASP A 118 PHE A 125 1 N VAL A 121 O VAL A 30 SHEET 4 S2 7 ASN A 37 SER A 42 -1 N TRP A 39 O VAL A 120 SHEET 5 S2 7 ILE A 94 PRO A 108 1 N VAL A 104 O VAL A 40 SHEET 6 S2 7 GLY A 78 VAL A 91 -1 N SER A 85 O PHE A 101 SHEET 7 S2 7 TYR A 64 TYR A 75 -1 N LEU A 71 O GLY A 82 SHEET 1 S3 9 LYS A 265 THR A 270 0 SHEET 2 S3 9 LEU A 255 LEU A 262 -1 N PHE A 260 O TYR A 267 SHEET 3 S3 9 VAL A 189 VAL A 199 -1 N SER A 198 O SER A 259 SHEET 4 S3 9 GLY A 209 ASP A 215 -1 N ALA A 212 O ILE A 192 SHEET 5 S3 9 GLY A 296 GLY A 302 1 N TRP A 299 O LEU A 211 SHEET 6 S3 9 TYR A 220 SER A 224 -1 N SER A 222 O ALA A 300 SHEET 7 S3 9 LYS A 281C PRO A 293 1 N HIS A 287 O ILE A 221 SHEET 8 S3 9 ASP A 244 LYS A 248 -1 N VAL A 247 O CYS A 282 SHEET 9 S3 9 ALA A 237 ARG A 240 -1 N LYS A 238 O VAL A 246 SSBOND 1 CYS A 45 CYS A 50 1555 1555 1.97 SSBOND 2 CYS A 206 CYS A 210 1555 1555 2.03 SSBOND 3 CYS A 249 CYS A 282 1555 1555 2.01 LINK ND2 ASN A 67 C1 NAG A 345 1555 1555 1.30 CISPEP 1 THR A 22 PRO A 23 0 -2.16 CISPEP 2 LEU A 110 PRO A 111 0 5.37 CISPEP 3 PRO A 293 PRO A 294 0 0.02 CISPEP 4 GLY A 296 PRO A 297 0 1.60 SITE 1 CAT 2 ASP A 32 ASP A 215 SITE 1 S4 5 THR A 12 SER A 219 TYR A 220 PHE A 242 SITE 2 S4 5 HIS A 287 SITE 1 S3 9 THR A 12 GLN A 13 THR A 77 PRO A 111 SITE 2 S3 9 PHE A 112 LEU A 114 ALA A 115 PHE A 117 SITE 3 S3 9 SER A 219 SITE 1 S2 8 SER A 76 THR A 77 ALA A 218 SER A 222 SITE 2 S2 8 HIS A 287 MET A 289 ILE A 291 ALA A 300 SITE 1 S1 9 VAL A 30 ASP A 32 TYR A 75 THR A 77 SITE 2 S1 9 PHE A 112 PHE A 117 VAL A 120 ASP A 215 SITE 3 S1 9 GLY A 217 SITE 1 S1' 7 SER A 76 LEU A 213 ASP A 215 ILE A 291 SITE 2 S1' 7 PRO A 292 THR A 295 ALA A 300 SITE 1 S2' 7 GLY A 34 SER A 35 LEU A 73 ARG A 74 SITE 2 S2' 7 TYR A 75 GLN A 128 ILE A 130 CRYST1 90.900 90.900 109.400 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011001 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011001 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009141 0.00000